StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
74
This year
1
Publishing Date
2022 - 12 - 01
1
2022 - 11 - 07
1
2022 - 11 - 04
1
2022 - 11 - 02
1
2022 - 10 - 20
2
2022 - 09 - 23
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 23
1
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 07 - 01
1
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
2021 - 09 - 23
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 30
2
2021 - 08 - 11
1
2021 - 07 - 12
1
2021 - 07 - 06
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 06 - 14
1
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 12
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 19
1
2021 - 03 - 18
2
2021 - 03 - 16
1
Sector
Finance
5
Finance and insurance
3
Health technology
74
Manufacturing
1
Tags
Biotech
1
Blood
1
Business
1
Cancer
4
Candidate
1
Cell
1
Clearance
1
Clinical-trials-phase-ii
1
Clinical-trials-phase-iii
2
Collaboration
2
Conference
19
Covid
1
Covid-19
1
Drug
1
Earnings
5
Europe
6
Events
18
Expansion
2
Financial
4
Financial results
4
Growth
1
Iph5201
2
Iph6101
1
Market
1
Money
2
N/a
27
Natural
2
News
1
Ongoing
1
Payment
1
Pharma
64
Pharmaceutical
8
Phase 1
1
Phase 2
4
Phase 2b
1
Phase 3
1
Platform
2
Presentation
3
Product-news
1
Regulatory
2
Report
3
Research
1
Response
1
Results
10
Sanofi
4
Study
1
Therapeutics
2
Trial
9
Update
7
Year
1
Entities
Abbvie inc.
1
Amgen inc.
1
Argenx se
1
Astellas pharma inc
1
Astrazeneca plc
4
Biogen inc.
1
Bnp paribas
3
Bristol-myers squibb company
2
Denali therapeutics inc.
1
Eli lilly and company
1
Glaxosmithkline plc
1
Incyte corporation
1
Innate pharma s.a.
74
Innate pharma sa
45
Johnson & johnson
1
Morgan stanley
1
Novartis ag
1
Novo nordisk a/s
71
Sanofi
73
Svb financial group
1
Takeda pharmaceutical company limited
2
Teva pharmaceutical industries ltd
1
Vertex pharmaceuticals incorporated
1
Zai lab limited
1
Symbols
AAPL
546
ABB
1433
ABBV
1030
ABLZF
1172
ABT
1797
ACN
602
ARVL
595
BDX
796
BMO
545
BMY
664
BNPQF
655
BNPQY
655
BSX
577
CMI
542
CSCO
532
DELL
579
DHR
786
DOW
557
DUK
530
ERIC
547
F
643
FNCTF
1407
GE
919
GLAXF
660
GOOG
787
GOOGL
788
GSK
887
HON
1794
HUBS
1400
IBM
658
IT
595
JNJ
4608
LLY
1712
LMT
576
LYV
717
MDT
1286
MMM
938
MS
4300
MSFT
808
MT
593
NOC
591
NOK
917
NOKBF
922
NVO
636
NVS
1245
NVSEF
1035
ORCL
1161
PFE
693
PHG
963
SAP
1481
SAPGF
1235
SNOW
796
SNY
1641
SNYNF
1312
STLA
536
SYK
536
TMO
1630
TRU
534
VZ
1223
XYF
679
Exchanges
Nasdaq
120
Nyse
74
Crawled Date
2022 - 12 - 01
1
2022 - 11 - 07
1
2022 - 11 - 04
1
2022 - 11 - 02
1
2022 - 10 - 20
2
2022 - 09 - 23
1
2022 - 09 - 15
1
2022 - 09 - 08
1
2022 - 09 - 05
1
2022 - 08 - 23
1
2022 - 08 - 01
1
2022 - 07 - 28
1
2022 - 07 - 21
1
2022 - 07 - 01
1
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
2021 - 09 - 23
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 30
2
2021 - 08 - 11
1
2021 - 07 - 12
1
2021 - 07 - 06
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 06 - 14
1
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 12
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 19
1
2021 - 03 - 18
2
2021 - 03 - 16
1
Crawled Time
05:00
2
06:00
20
07:00
16
08:00
10
09:00
6
10:00
6
11:00
6
12:00
4
12:30
1
20:00
1
22:00
1
23:00
1
Source
www.biospace.com
47
www.globenewswire.com
25
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
IPHA
exchanges :
Nyse
save search
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
-3.3%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$135.35
-3.53%
-4.19%
0
|
Health Technology
|
12.17%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
News
|
$9.47
-0.21%
-1.11%
20K
|
Manufacturing
|
-12.48%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-7.55%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
-2.17%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$148.53
-0.69%
0.11%
67K
|
Health Technology
|
-5.41%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
0.91%
11K
|
Health Technology
|
-0.51%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$732.2
-1.81%
-0.71%
8K
|
Health Technology
|
2.03%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.86
-0.27%
0.98%
14M
|
Health Technology
|
-1.79%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$167.8
-1.03%
-0.02%
2.9M
|
Health Technology
|
-3.05%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$15.66
3.57%
3.45%
430K
|
Health Technology
|
-14.0%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
$400.76
-1.03%
-1.06%
810K
|
Health Technology
|
-4.25%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
2.69%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
-4.65%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$51.74
0.17%
0.14%
2
|
Health Technology
|
-10.55%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$201.99
4.56%
4.32%
420
|
Health Technology
|
-17.47%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$71.2
0.49%
0.46%
300K
|
Health Technology
|
15.94%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$375.0
-0.02%
-0.02%
0
|
Health Technology
|
-4.51%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
News
|
$273.01
-0.19%
-0.17%
400
|
Health Technology
|
-7.28%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published:
2023-12-19
(Crawled : 08:00)
- biospace.com/
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
27.46%
|
O:
0.91%
H:
0.72%
C:
0.11%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
-2.07%
|
O:
0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
0.41%
|
O:
13.88%
H:
0.0%
C:
-3.58%
pharma
natural
cell
sanofi
Innate Pharma Announces Its Participation to Upcoming Investor Conferences and Conference Call for First Half 2023 Business Update
Published:
2023-08-29
(Crawled : 07:00)
- biospace.com/
MS
|
News
0 d
|
$93.85
0.1%
-0.1%
2.1K
|
Finance
|
11.02%
|
O:
0.64%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
-11.83%
|
O:
0.34%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
-10.22%
|
O:
6.57%
H:
0.34%
C:
-4.11%
pharma
conference
business
update
Innate Pharma Announces Conference Call and Webcast for Full Year 2022 Financial Results
Published:
2023-03-16
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
-0.64%
|
O:
-0.07%
H:
1.96%
C:
0.56%
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
-10.51%
|
O:
-1.4%
H:
0.03%
C:
-0.08%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
0.71%
|
O:
1.01%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
-20.35%
|
O:
-6.11%
H:
3.54%
C:
0.69%
pharma
conference
year
financial
Innate Pharma Provides Update on Silicon Valley Bank Exposure
Published:
2023-03-13
(Crawled : 09:00)
- biospace.com/
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
-10.71%
|
O:
-0.02%
H:
1.44%
C:
-0.51%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
-0.67%
|
O:
-0.81%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
-16.47%
|
O:
2.21%
H:
4.65%
C:
-1.66%
pharma
update
Number of Shares and Voting Rights of Innate Pharma as of February 1, 2023
Published:
2023-02-21
(Crawled : 10:00)
- biospace.com/
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
-10.92%
|
O:
0.55%
H:
0.77%
C:
0.14%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
0.19%
|
O:
0.79%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
-22.88%
|
O:
-3.76%
H:
0.0%
C:
-0.65%
pharma
Innate Pharma to Participate in Upcoming Investor Conferences - February 07, 2023
Published:
2023-02-07
(Crawled : 10:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
1.21%
|
O:
-1.0%
H:
0.0%
C:
0.0%
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
-8.63%
|
O:
0.19%
H:
1.01%
C:
0.91%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
4.17%
|
O:
1.64%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
-27.65%
|
O:
-0.74%
H:
2.52%
C:
1.33%
pharma
Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers
Published:
2023-01-25
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
-4.4%
|
O:
-0.92%
H:
1.41%
C:
1.41%
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
-9.82%
|
O:
-1.97%
H:
1.74%
C:
1.28%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
-2.18%
|
O:
0.39%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
-32.04%
|
O:
-0.28%
H:
1.66%
C:
-0.28%
clearance
expansion
pharma
collaboration
sanofi
Press Release: Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology
Published:
2022-12-19
(Crawled : 07:00)
- globenewswire.com
IPHYF
|
$2.65
104.6%
300
|
Health Technology
|
21.31%
|
O:
21.77%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
1.9%
|
O:
1.54%
H:
0.51%
C:
-0.25%
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
-5.27%
|
O:
-1.82%
H:
0.23%
C:
-0.11%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
2.03%
|
O:
1.14%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
29.47%
|
O:
35.79%
H:
10.85%
C:
2.71%
pharma
collaboration
natural
therapeutics
sanofi
Number of Shares and Voting Rights of Innate Pharma as of December 1, 2022
Published:
2022-12-09
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
-1.1%
|
O:
-0.89%
H:
0.0%
C:
0.0%
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
-1.28%
|
O:
1.97%
H:
0.41%
C:
-1.07%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
1.31%
|
O:
-0.15%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
20.0%
|
O:
3.41%
H:
2.83%
C:
0.0%
pharma
Innate Pharma to present adenosine franchise, IPH5201 and IPH5301 at ESMO IO 2022
Published:
2022-12-01
(Crawled : 08:00)
- biospace.com/
IPHYF
|
$2.65
104.6%
300
|
Health Technology
|
21.07%
|
O:
5.99%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
4.16%
|
O:
2.64%
H:
2.88%
C:
2.88%
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
1.25%
|
O:
1.25%
H:
0.2%
C:
-0.02%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
6.5%
|
O:
2.96%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
14.42%
|
O:
4.56%
H:
1.86%
C:
1.86%
iph5201
pharma
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2022 Business Update
Published:
2022-11-07
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
7.92%
|
O:
-2.01%
H:
0.88%
C:
0.88%
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
12.23%
|
O:
0.91%
H:
1.82%
C:
1.43%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
9.57%
|
O:
-0.46%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
13.36%
|
O:
-1.38%
H:
2.8%
C:
1.87%
pharma
conference
update
Innate Pharma to Present Results From a Preliminary Analysis of the TELLOMAK Phase 2 Trial in Patients With Advanced Sezary Syndrome and ANKET™ Platform at ASH 2022
Published:
2022-11-04
(Crawled : 10:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
8.36%
|
O:
-0.02%
H:
0.43%
C:
0.43%
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
10.79%
|
O:
-0.25%
H:
0.11%
C:
-1.03%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
11.82%
|
O:
2.05%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
16.04%
|
O:
-4.27%
H:
8.9%
C:
6.93%
pharma
trial
results
platform
Innate Pharma to Participate in Upcoming Investor Conferences - November 02, 2022
Published:
2022-11-02
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
5.38%
|
O:
-2.21%
H:
0.0%
C:
-0.14%
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
18.54%
|
O:
4.84%
H:
4.18%
C:
1.48%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
9.83%
|
O:
0.07%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
12.33%
|
O:
-5.48%
H:
2.42%
C:
-0.97%
pharma
Innate Pharma 2023 Financial Calendar
Published:
2022-10-20
(Crawled : 07:00)
- biospace.com/
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
20.6%
|
O:
-0.35%
H:
1.28%
C:
-0.17%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
18.6%
|
O:
-1.19%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
18.27%
|
O:
0.0%
H:
2.4%
C:
1.92%
pharma
financial
Innate Pharma 2023 Financial Calendar Innate Pharma SA released its 2023 financial calendar. argenx to Report Third Quarter 2022 Financial Results and Business Update on October 27, 2022 argenx announc...
Published:
2022-10-20
(Crawled : 07:00)
- biospace.com/
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
20.6%
|
O:
-0.35%
H:
1.28%
C:
-0.17%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
18.6%
|
O:
-1.19%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
18.27%
|
O:
0.0%
H:
2.4%
C:
1.92%
DNLI
|
$15.56
-3.41%
-3.6%
40
|
Health Technology
|
-44.17%
|
O:
-5.24%
H:
10.87%
C:
5.45%
pharma
report
financial
update
results
Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Mycosis Fungoides
Published:
2022-09-23
(Crawled : 06:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
23.68%
|
O:
5.45%
H:
0.0%
C:
-8.46%
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
28.33%
|
O:
-0.53%
H:
0.81%
C:
0.14%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
21.53%
|
O:
-1.69%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
-0.4%
|
O:
-2.02%
H:
0.41%
C:
-3.72%
ongoing
pharma
trial
phase 2
Innate Pharma Reports First Half 2022 Financial Results and Business Update
Published:
2022-09-15
(Crawled : 06:00)
- biospace.com/
BNPQF
|
News
|
$70.45
2.76%
-13.4%
0
|
Finance
|
40.23%
|
O:
-1.65%
H:
0.0%
C:
-2.85%
BNPQY
|
News
|
$36.5
0.11%
-2.68%
1
|
Finance and Insurance
|
45.53%
|
O:
-1.12%
H:
2.34%
C:
1.69%
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
12.31%
|
O:
1.6%
H:
0.0%
C:
-6.5%
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
20.11%
|
O:
-0.88%
H:
0.45%
C:
-0.87%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
17.55%
|
O:
0.4%
H:
0.84%
C:
0.37%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
0.0%
|
O:
3.25%
H:
0.0%
C:
0.0%
pharma
financial
update
results
Innate Pharma Announces Conference Call and Webcast for First Half 2022 Business Update
Published:
2022-09-08
(Crawled : 06:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
22.46%
|
O:
-0.65%
H:
0.0%
C:
0.0%
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
20.35%
|
O:
-0.72%
H:
1.61%
C:
1.55%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
18.52%
|
O:
-0.47%
H:
0.0%
C:
0.0%
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
-5.02%
|
O:
1.54%
H:
0.76%
C:
-1.52%
pharma
conference
update
Innate Pharma to Present Lacutamab PTCL Phase 1b Design and ANKET™ Platform at ESMO 2022
Published:
2022-09-05
(Crawled : 08:00)
- biospace.com/
IPHA
|
$2.46
3.8%
4.05%
690
|
Health Technology
|
Email alert
Add to watchlist
NVO
|
News
|
$126.16
-1.93%
-2.24%
3M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
0
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
IPHYF
|
$2.65
104.6%
300
|
Health Technology
|
Email alert
Add to watchlist
pharma
platform
phase 2b
← Previous
1
2
3
4
Next →
Gainers vs Losers
61%
39%
Top 10 Gainers
BOF
|
$2.08
77.78%
39.06%
110M
|
BHIL
|
$0.1793
-4.37%
19.24%
340K
|
Agriculture, Forestry, Fishing ...
UMAC
|
$1.48
-1.33%
14.87%
20K
|
CI
|
$352.28
-0.11%
13.53%
2
|
Health Services
CIG.C
|
$2.89
-1.37%
12.8%
2.3K
|
n/a
BMTX
4
|
$1.545
0.98%
10.03%
2.5K
|
Information
TAL
|
$12.26
0.57%
9.22%
12M
|
Consumer Services
MTH
|
$154.69
-2.21%
7.56%
64
|
Consumer Durables
ASXC
|
$0.243
-2.41%
7.0%
1.1M
|
Manufacturing
IHT
P
|
$1.3712
0.82%
6.48%
0
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.